Tetratherix Limited (ASX:TTX)
Australia · Delayed Price · Currency is AUD 6.25
-0.26 (-3.99%)
Sep 17, 2026, 4:10 PM AEST
Tetratherix Market Cap
Tetratherix has a market cap or net worth of 345.41 million as of September 16, 2026. Its market cap has increased by 63.40% in one year.
Market Cap
345.41M
Enterprise Value
322.01M
Revenue
3.86M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.25
ChartMarket Cap Chart
Since June 30, 2025, Tetratherix's market cap has increased from 152.00M to 345.41M, an increase of 127.24%. That is a compound annual growth rate of 96.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 345.41M | 109.23% |
| Dec 30, 2025 | 165.09M | 8.61% |
| Jun 30, 2025 | 152.00M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Clarity Pharmaceuticals | 798.39M |
| Clinuvel Pharmaceuticals | 419.06M |
| Racura Oncology | 392.14M |
| Starpharma Holdings | 352.87M |
| BLS Pharmaceuticals | 268.30M |
| Actinogen Medical | 223.16M |
| Orthocell | 196.08M |
| Nyrada | 166.79M |